Validation of an HPLC method for the determination of imatinib mesylate in pharmaceutical dosage

Journal of Liquid Chromatography and Related Technologies

Volumn 28, Issue 20, 2005, Pages 3283-3292

  Rosasco, María A ^a   Moyano, María A ^a   Pizzorno, María T ^a   Segall, Adriana I ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Assay; HPLC; Imatinib mesylate; Stability indicating method

Indexed keywords

DISTILLATION COLUMNS; DRUG PRODUCTS; HIGH PRESSURE LIQUID CHROMATOGRAPHY; ULTRAVIOLET DETECTORS;

IMATINIB MESYLATE; STABILITY-INDICATING METHOD; SULFONIC ACID;

AROMATIC HYDROCARBONS;

HEPTANE DERIVATIVE; IMATINIB; SULFONE;

ACCURACY; ARTICLE; EVALUATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; QUANTITATIVE ANALYSIS; ULTRAVIOLET SPECTROSCOPY; VALIDATION PROCESS;

EID: 28744443736     PISSN: 10826076     EISSN: 1520572X     Source Type: Journal    
DOI: 10.1080/10826070500330976     Document Type: Article

References (8)

1. Bakhtiar, R.; Khemani, L.; Hayes, M.; Bedman, T.; Tse, F. Quantification of the anti-leukemia drug STI571 (Gleevec™) and its metabolite (CGP 74588) in monkey plasma using a semi-automated solid phase extraction procedure and liquid chromatography-tandem mass spectrometry. J. Pharm. Biomed. Anal. 2002, 28, 1183-1194.
2. Parise, R.A.; Ramanathan, R.K.; Hayes, M.J.; Egorin, M.J. Liquid chromatographic-mass spectrometric assay for quantitation of Imatinib and its main metabolite (CGP 74588) in plasma. J. Chromatogr. B 2003, 791, 39-44.
3. Bakhtiar, R.; Lohne, J.; Ramos, L.; Khemani, L.; Hayes, M.; Tse, F. High-throughput quantification of the anti-leukemia drug STI571 (Gleevec™) and its main metabolite (CGP 74588) in human plasma using liquid chromatography-tandem mass spectrometry. J. Chromatogr. B 2002, 768, 325-340.
4. Vivekanand, V.V.; Sreenivas Rao, D.; Vaidyanathan, G.; Sekhar, N.M.; Avijit Kelkar, S.; Ramachandra Puranik, P. A validated LC method for imatinib mesylate. J. Pharm. Biomed. Anal. 2003, 33, 879-889.
5. Medenica, M.; Jancic, B.; Ivanovic, D.; Malenovic, A. Experimental design in reversed-phase high-performance liquid chromatographic analysis of imatinib mesylate and its impurity. J. Chromatogr. A 2004, 1031, 243-248.
6. Ivanovic, D.; Medenica, M.; Jancic, B.; Malenovic, A. Reversed-phase liquid chromatographic analysis of imatinib mesylate and its impurity product in Glivec® capsules. J. Chromatogr. B 2004, 800, 253-258.
7. International Conference on Harmonization. Guideline on Validation of Analytical Procedures, 1996.
8. The United States Pharmacopeia. U. S. Pharmacopeial Convention: Rockville, MD, 2003; Vol. 27, 2272-2284.